AI Drug Discovery Gets Smarter with Better Data Systems

A global life sciences company is solving AI's biggest weakness in pharmaceutical research: incomplete data that slows down breakthrough treatments.

New tools are helping scientists validate AI-generated drug candidates faster and more accurately than ever before.